Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (600721.SS)
- Previous Close
6.67 - Open
6.76 - Bid 6.62 x --
- Ask 6.63 x --
- Day's Range
6.62 - 6.76 - 52 Week Range
5.07 - 8.67 - Volume
14,803,900 - Avg. Volume
26,811,370 - Market Cap (intraday)
2.547B - Beta (5Y Monthly) 0.15
- PE Ratio (TTM)
60.27 - EPS (TTM)
0.11 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date May 22, 1997
- 1y Target Est
--
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in the pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. The company was formerly known as Xinjiang Baihuacun Co., Ltd. and changed its name to Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021. Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd was founded in 1959 and is based in Urumqi, China.
www.xjbhc.netRecent News: 600721.SS
View MorePerformance Overview: 600721.SS
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600721.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600721.SS
View MoreValuation Measures
Market Cap
2.55B
Enterprise Value
2.30B
Trailing P/E
61.16
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.48
Price/Book (mrq)
3.27
Enterprise Value/Revenue
5.87
Enterprise Value/EBITDA
23.60
Financial Highlights
Profitability and Income Statement
Profit Margin
10.75%
Return on Assets (ttm)
1.76%
Return on Equity (ttm)
5.66%
Revenue (ttm)
385.76M
Net Income Avi to Common (ttm)
41.48M
Diluted EPS (ttm)
0.11
Balance Sheet and Cash Flow
Total Cash (mrq)
272.05M
Total Debt/Equity (mrq)
0.01%
Levered Free Cash Flow (ttm)
66.32M